DBT JRF 2020 [BET 2020] Notification | Exam on June 30, 2020


DEPARTMENT OF BIOTECHNOLOGY 
Ministry of Science &Technology, Govt. of India 

DBT-Junior Research Fellowship (DBT-JRF) in Biotechnology (2020) 
BIOTECHNOLOGY ELIGIBILITY TEST (BET) 2020 

Applications are invited from bonafide Indian citizens, residing in India for award of "DBT-Junior Research Fellowship" (DBT-JRF) for pursuing research in frontier areas of Biotechnology and Life Sciences. The candidates will be selected through "Biotechnology Eligibility Test (BET)". Based on the performance in BET, two categories of merit list will be prepared (Category-I and Category-II). Government of India norms for reservation will be followed for selection. Candidates selected under category-I will be eligible to avail fellowship under the programme. These will be tenable at any University/Institute in India where the selected candidate registers for PhD Programme. Candidates selected under Category-II will be eligible to be appointed in any DBT sponsored project and avail fellowship from the project equivalent to NET/GATE, subject to selection through institutional selection process. There will be no binding on Principal Investigators of DBT sponsored projects to select JRF for their project from category-II list. Selection in category-II will not entitle student for any fellowship from DBT-JRF programme. 

ELIGIBILITY 

Qualification: M.Sc./ M.Tech./ M.V.Sc. or equivalent degree/ Integrated BS-MS/ B.E./ B.Tech. in any discipline of Biotechnology, M.Sc./ M.Tech. Bioinformatics/ Computational Biology, students admitted under DBT supported Postgraduate Teaching Programs. M.Sc. Life Science/ Bioscience/ Zoology/ Botany/ Microbiology/ Biochemistry/ Biophysics and Masters in Allied areas of Biology/Life Sciences. 

Candidates appearing in the final year examination are also eligible to apply. 

Marks: Minimum 60% marks for General, EWS & OBC category and 55% for SC/ ST/ Differently abled in aggregate (or equivalent grade). 

Age Limit: Upto 28 years as on the last date of application for General & EWS category. Age relaxation of up to 5 years (33 years) for SC/ ST/ Differently Abled/ women candidates and upto 3 years (31 years) for OBC (Non-Creamy Layer) candidates. 

DETAILS OF THE AWARD 

DBT-BET (category-I) entitles a candidate for activation of fellowship subject to joining of PhD Programme and registration from a recognized university or Institute in the country within 2 years from the date of issue of award letter. Registration for PhD is candidate's responsibility and DBT has no role/ responsibility in this matter. Verification of documents will be carried out for shortlisted candidates. Award letter will not be issued to candidates found ineligible or who submit incorrect documents. 

MODE OF SELECTION The candidates will be selected by computer based, "Biotechnology Eligibility Test (BET)". A candidate may opt for any three centers of their choice from the options given in the application form. Efforts would be made to allot one of the three opted cities/ centers however, in certain cases a candidate may be allotted a different city/ center due to administrative reasons. No TA/DA will be admissible to any candidate for attending the test. 

MODE OF APPLICATION For detailed procedure for filling the application form, payment of application fee and uploading of required documents/ certificates in the prescribed format, please visit: http://rcb.res.in/BET2020. A non-refundable and non-transferable application fee of Rs. 1000/-is payable online by General/ OBC/ EWS candidates and Rs 250/- by SC/ ST/ Differently abled candidates. 

IMPORTANT DATES EVENT DATE 

Online registration start date April 20, 2020 
Online registration close May 18, 2020 
BET 2020 June 30, 2020 (Tuesday) 
Tentative Display of Question Paper and Answer June 30, 2020 
Key on Website Last date of accepting representation of any discrepancy in Question paper and Answer Key July 3, 2020  
Declaration of BET 2020 Results July 20, 2020 

To Get All Updates from helpBIOTECH, Subscribe Now by Email



Post a comment

0 Comments